Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Indoles Stories

2013-02-25 16:26:33

WAYNE, N.J. and SOUTH SAN FRANCISCO, Calif., Feb. 25, 2013 /PRNewswire/ -- Intended for U.S. Media Only -- Bayer HealthCare and Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) announced today that the U.S. Food and Drug Administration (FDA) approved Bayer's Stivarga(®) (regorafenib) tablets to treat patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate.(1 )Stivarga...

2012-11-28 00:22:09

EAST HANOVER, N.J., Nov. 28, 2012 /PRNewswire/ -- Novartis will highlight more than 140 presentations on key data from its extensive oncology portfolio at the leading year-end scientific meetings devoted to hematology and breast cancer, demonstrating continued innovation in research and development efforts to advance the care of patients with cancer and rare diseases. The American Society of Hematology (ASH) annual meeting in Atlanta, held December 8-11, will feature significant data across...

2012-11-23 10:50:21

A new targeted drug demonstrated its ability to control metastatic gastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma, after the disease had become resistant to all existing therapies, report investigators at Dana-Farber Cancer Institute who led the worldwide clinical trial. The treatment of gastrointestinal stromal tumor, or GIST, even in its advanced metastatic stage, has been dramatically improved with two oral targeted drugs — imatinib (Gleevec) and...

2012-10-12 07:22:58

THE WOODLANDS, Texas, Oct. 12, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced positive, top-line data from a recently completed Phase 2 study in carcinoid syndrome with telotristat etiprate. Results from the trial will be presented at the North American Neuroendocrine Tumor Society on Saturday, October 13, 2012 in San Diego, California. Carcinoid syndrome is a chronic...

2012-10-02 02:30:21

YARDLEY, Pa., Oct. 2, 2012 /PRNewswire/ -- OptiNose US Inc. today announced results of a study testing delivery of the migraine medicine sumatriptan with a novel device using OptiNose breath powered Bi-Directional(TM) nasal technology. In a direct comparison of drug absorption, the study found that OptiNose's sumatriptan product sent 62% more drug into the blood in the critical first 15 minutes than Imitrex(®) nasal spray (AUC (0-15) = 1.69 ng*hr/mL and 1.04 ng*hr/mL, respectively). The...

Could Magic Mushrooms Help Treat Depression?
2012-01-24 05:56:50

Brain scans of individuals under the influence of so-called magic mushrooms have given scientists the clearest illustration yet as to how such psychedelic drugs can affect people, while also providing hope that the active ingredient in this substance could be used to help treat depression. In two separate studies announced Monday, researchers discovered that the ingredient in question, psilocybin, does not increase activities in areas of the brain that tend to be suppressed by...

Lasting Happiness Found With Hallucinogen Use?
2011-09-29 11:24:00

Researchers from Johns Hopkins University School of Medicine studying psilocybin, the mind-altering chemical in “magic mushrooms,” found that the chemical may actually alter people´s personalities for a long period of time, ABC News is reporting. The study involved one high dose of psilocybin administered to 51 adult study participants and found that 30 of them underwent measurable personality changes lasting more than a year. The aspect of personality that changed is...

8865ab1e0fb94884dcf198aa022c5d81
2011-06-16 11:00:00

The hallucinogen found in "magic mushrooms" could be used to treat a variety of psychiatric disorders, including depression, anxiety and addiction, according to researchers working on a new study. The scientists, working at Johns Hopkins University School of Medicine have figured out the dose levels of the "sacred mushroom" chemical capable of yielding positive experiences, while minimizing the chance of negative reactions like those found in volunteers of the study, who were under constant,...

2010-09-09 14:14:00

BEDFORD, Ohio, Sept. 7 /PRNewswire/ --- Bedford Laboratories(TM) is excited to announce they have further diversified their product offerings with the addition of pre-filled syringes. FDA approval has been granted and Sumatriptan Succinate Injection, 6mg (base)/0.5 mL pre-filled syringes are now available. This is a very important product addition to their expanding portfolio of products. Sumatriptan Succinate Injection is indicated for the acute treatment of migraine attacks with or...

9695e60128830e10564e115c80c25b5b
2010-09-07 12:24:56

U.S. researchers said Monday that magic mushrooms may help ease the anxiety that accompanies late-stage cancer. They said that cancer patients given a moderate dose of the hallucinogen psilocybin were measurably less depressed six months after a single dose compared with a placebo. The study of 12 cancer patients was designed to prove that hallucinogenic drugs could be studied as a way to relieve the distress of advanced cancer. The study, which was published in the Archives of General...